Table 2:
Expression profiles of markers on plasma cells
| Rank | Antigen | Frequency of antigen expression on plasma cellsa |
Sensitivity, %b | |
|---|---|---|---|---|
| Mean ± SD | Range | |||
| 1c | CD319 | 99.6 ± 0.5 | 98.5 – 100 | 100.0 |
| 2c | CD54 | 99.5 ± 0.6 | 97.6 – 100 | 100.0 |
| 3c | CD229 | 99.0 ± 1.4 | 95.7 – 100 | 100.0 |
| 4 | CD317 | 94.8 ± 9.3 | 68.5 – 100 | 76.9 |
| 5 | p63 | 93.3 ± 13.6 | 52.9 – 99.8 | 83.3 |
| 6 | CD48 | 86.4 ± 13.7 | 48.3 – 99.9 | 46.2 |
| 7 | CD29 | 89.4 ± 13 | 65.5 – 99.7 | 61.5 |
| 8 | CD47 | 90.4 ± 9.4 | 74.5 – 98.4 | 53.8 |
| 9 | CD269 | 89.1 ± 19.2 | 28.4 – 99.7 | 76.9 |
| 10 | CD352 | 81.4 ± 31.1 | 15.9 – 100 | 69.2 |
| 11 | CD150 | 72.6 ± 41.1 | 0.4 – 99.9 | 61.5 |
| 12 | CD307 | 51.8 ± 40.2 | 5.6 – 98.9 | 30.8 |
| 13 | CD84 | 37.2 ± 29.5 | 6.6 – 83.9 | 0.0 |
| 14 | CD244 | 22.8 ± 31.5 | 0.4 – 77.8 | 0.0 |
| 15 | CD353 | 7.2 ± 19.9 | 0.2 – 73.2 | 0.0 |
| 16 | CD40 | 1.9 ± 2.3 | 0.1 – 8.3 | 0.0 |
Plasma cells were defined as CD38br, CD138+, and CD45lo
Percentage of patient cases with >90% plasma cells expressing the antigen
Markers selected for further analysis
Sample size (n) = 13; except p63 (n) = 12